GIOVE A, the first Galileo satellite, departed from ESA’s test facility at the European Space Research and Technology Centre in The Netherlands on the morning of 29 November, bound for the Baikonur Cosmodrome in Kazakhstan.
The spacecraft, packed in its transport container and accompanied by its support equipment, was taken by road from the European Space Research and Technology Centre (ESTEC) to Amsterdam’s Schiphol airport, where it was loaded onto an Antonov transport plane.
GIOVE-A was flown first to Moscow and, after customs formalities had been completed, made the second leg of its air journey to Baikonur, arriving in the early hours of 30 November. It will be placed in orbit by a Soyuz/Fregat launch vehicle, with lift-off scheduled for late December.
GIOVE-A has been developed by Surrey Satellite Technology Ltd (UK). Galileo Industries (GaIn) is developing the GIOVE-B satellite. GaIn is a European consortium including Alcatel Alenia Space (F/I), Astrium (D/UK) and Galileo Sistemas y Servicios (E).
GIOVE B is undergoing final integration and testing at the Rome facilities of Alcatel Alenia Space, prior to moving to the European Space Research and Technology Centre (ESTEC) for its environmental test campaign. It is due to be launched in 2006.
Experience gained from the GIOVE missions will support the development of the Galileo IOV system. The next phase of Galileo IOV will be the deployment of the first four of 30 fully representative Galileo satellites that will be required for full system operation.
Dominique Detain | alfa
UNLV study unlocks clues to how planets form
13.12.2018 | University of Nevada, Las Vegas
Unprecedented Views of the Birth of Planets
13.12.2018 | Universität Heidelberg
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences